{"id":4410,"date":"2026-09-25T07:23:46","date_gmt":"2026-09-25T07:23:46","guid":{"rendered":"https:\/\/oncohep.com\/sp\/?post_type=product&#038;p=4410"},"modified":"2026-09-28T07:26:16","modified_gmt":"2026-09-28T07:26:16","slug":"pertuzumab-420-mg-14-ml-sigrima-inyeccion","status":"publish","type":"product","link":"https:\/\/oncohep.com\/sp\/producto\/pertuzumab-420-mg-14-ml-inyeccion\/","title":{"rendered":"PERTUZUMAB 420 mg\/14 mL (Sigrima) inyecci\u00f3n"},"content":{"rendered":"<p>El pertuzumab es un anticuerpo dirigido contra HER2 que se utiliza en determinados tipos de c\u00e1ncer de mama HER2 positivo. Normalmente se combina con trastuzumab y otros tratamientos contra el c\u00e1ncer prescritos. El equipo de oncolog\u00eda comprueba el estado de HER2 y la funci\u00f3n card\u00edaca antes de elegir una combinaci\u00f3n de tratamientos.<\/p>\n<table class=\"table\" border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><strong>Fabricante<\/strong><\/td>\n<td>Zydus Lifesciences Ltd<\/td>\n<\/tr>\n<tr>\n<td><strong>Nombre gen\u00e9rico<\/strong><\/td>\n<td>PERTUZUMAB <\/td>\n<\/tr>\n<tr>\n<td><strong>Fortaleza<\/strong><\/td>\n<td>420 mg<\/td>\n<\/tr>\n<tr>\n<td><strong>Tama\u00f1o del paquete<\/strong><\/td>\n<td>Inyecci\u00f3n de 14 ml<\/td>\n<\/tr>\n<tr>\n<td><strong>Usado para<\/strong><\/td>\n<td>Breast cancer<\/td>\n<\/tr>\n<tr>\n<td><strong>Disponibilidad<\/strong><\/td>\n<td>En stock<\/td>\n<\/tr>\n<tr>\n<td><strong>Env\u00edos a<\/strong><\/td>\n<td>M\u00e9xico, Colombia, Per\u00fa, Venezuela, Chile, Guatemala, Ecuador, Bolivia, Panam\u00e1, Honduras, Costa Rica, Argentina, Cuba, Brasil, El Salvador y otros pa\u00edses.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\/\",\n  \"@type\": [\"Product\", \"Drug\"],\n  \"name\": \"PERTUZUMAB 420 mg\/14 mL (Sigrima) inyecci\u00f3n\",\n  \"image\": \"https:\/\/oncohep.com\/sp\/wp-content\/uploads\/2026\/09\/pertuzumab-420-mg-14-ml-sigrima-inyeccion.webp\",\n  \"url\": \"https:\/\/oncohep.com\/sp\/producto\/pertuzumab-420-mg-14-ml-inyeccion\/\",\n  \"description\": \"Sigrima contiene pertuzumab 420 mg\/14 mL, un anticuerpo dirigido contra HER2 utilizado en determinados tratamientos para el c\u00e1ncer de mama HER2 positivo bajo supervisi\u00f3n oncol\u00f3gica.\",\n  \"brand\": {\"@type\": \"Brand\", \"name\": \"Sigrima\"},\n  \"manufacturer\": {\"@type\": \"Organization\", \"name\": \"Zydus Lifesciences Ltd\"},\n  \"offers\": {\n    \"@type\": \"Offer\",\n    \"url\": \"https:\/\/oncohep.com\/sp\/producto\/pertuzumab-420-mg-14-ml-inyeccion\/\",\n    \"priceCurrency\": \"USD\",\n    \"price\": \"690.00\",\n    \"itemCondition\": \"https:\/\/schema.org\/NewCondition\",\n    \"availability\": \"https:\/\/schema.org\/InStock\",\n    \"shippingDetails\": {\n      \"@type\": \"OfferShippingDetails\",\n      \"shippingRate\": {\"@type\": \"MonetaryAmount\", \"value\": \"20.00\", \"currency\": \"USD\"},\n      \"shippingDestination\": {\n        \"@type\": \"DefinedRegion\",\n        \"name\": \"M\u00e9xico, Colombia, Espa\u00f1a, Argentina, Per\u00fa, Venezuela, Chile, Guatemala, Ecuador, Bolivia, Cuba, Rep\u00fablica Dominicana, Honduras, Paraguay, El Salvador, Nicaragua, Costa Rica, Panam\u00e1, Uruguay, Guinea Ecuatorial\"\n      },\n      \"deliveryTime\": {\n        \"@type\": \"ShippingDeliveryTime\",\n        \"handlingTime\": {\"@type\": \"QuantitativeValue\", \"minValue\": 7, \"maxValue\": 14, \"unitCode\": \"d\"},\n        \"transitTime\": {\"@type\": \"QuantitativeValue\", \"minValue\": 7, \"maxValue\": 12, \"unitCode\": \"d\"}\n      }\n    },\n    \"seller\": {\n      \"@type\": \"Organization\",\n      \"name\": \"Oncohep - Farmacia Internacional de Confianza\",\n      \"url\": \"https:\/\/oncohep.com\/sp\/\",\n      \"logo\": \"https:\/\/oncohep.com\/sp\/wp-content\/uploads\/2025\/10\/logo.webp\",\n      \"contactPoint\": {\n        \"@type\": \"ContactPoint\",\n        \"telephone\": \"+91-98111 45497\",\n        \"contactType\": \"Customer Service\",\n        \"areaServed\": \"M\u00e9xico, Colombia, Espa\u00f1a, Argentina, Per\u00fa, Venezuela, Chile, Guatemala, Ecuador, Bolivia, Cuba, Rep\u00fablica Dominicana, Honduras, Paraguay, El Salvador, Nicaragua, Costa Rica, Panam\u00e1, Uruguay, Guinea Ecuatorial\",\n        \"availableLanguage\": [\"Spanish\", \"English\", \"Portuguese\"]\n      }\n    }\n  },\n  \"medicineSystem\": \"https:\/\/schema.org\/WesternConventional\",\n  \"activeIngredient\": \"Pertuzumab\",\n  \"doseForm\": \"Inyecci\u00f3n\",\n  \"strength\": \"420 mg\/14 mL\"\n}\n<\/script><\/p>\n","protected":false},"featured_media":4411,"template":"","meta":{"_acf_changed":false},"product_category":[153],"brand":[],"salt":[],"class_list":["post-4410","product","type-product","status-publish","has-post-thumbnail","hentry","product_category-inyecciones-oncologicas"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncohep.com\/sp\/wp-json\/wp\/v2\/product\/4410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncohep.com\/sp\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/oncohep.com\/sp\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncohep.com\/sp\/wp-json\/wp\/v2\/media\/4411"}],"wp:attachment":[{"href":"https:\/\/oncohep.com\/sp\/wp-json\/wp\/v2\/media?parent=4410"}],"wp:term":[{"taxonomy":"product_category","embeddable":true,"href":"https:\/\/oncohep.com\/sp\/wp-json\/wp\/v2\/product_category?post=4410"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/oncohep.com\/sp\/wp-json\/wp\/v2\/brand?post=4410"},{"taxonomy":"salt","embeddable":true,"href":"https:\/\/oncohep.com\/sp\/wp-json\/wp\/v2\/salt?post=4410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}